BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 19486447)

  • 1. Predictors of microscopic portal vein invasion by hepatocellular carcinoma: measurement of portal perfusion defect area ratio.
    Shirabe K; Kajiyama K; Abe T; Sakamoto S; Fukuya T; Akazawa K; Morita K; Maehara Y
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1431-6. PubMed ID: 19486447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins.
    Matsuda M; Suzuki T; Kono H; Fujii H
    J Hepatobiliary Pancreat Surg; 2007; 14(3):289-96. PubMed ID: 17520205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma.
    Choi KK; Kim SH; Choi SB; Lim JH; Choi GH; Choi JS; Kim KS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1646-51. PubMed ID: 21592228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.
    Koike Y; Nakagawa K; Shiratori Y; Shiina S; Imamura M; Sato S; Obi S; Teratani T; Hamamura K; Yoshida H; Omata M
    Hepatogastroenterology; 2003; 50(54):2035-9. PubMed ID: 14696460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments.
    Adachi E; Maeda T; Kajiyama K; Kinukawa N; Matsumata T; Sugimachi K; Tsuneyoshi M
    Cancer; 1996 May; 77(10):2022-31. PubMed ID: 8640665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
    J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological evaluation of intracapsular venous invasion for discrimination between portal and hepatic venous invasion in hepatocellular carcinoma.
    Ohashi M; Wakai T; Korita PV; Ajioka Y; Shirai Y; Hatakeyama K
    J Gastroenterol Hepatol; 2010 Jan; 25(1):143-9. PubMed ID: 19968750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.
    Kim BK; Han KH; Park YN; Park MS; Kim KS; Choi JS; Moon BS; Chon CY; Moon YM; Ahn SH
    J Surg Oncol; 2008 Mar; 97(3):246-52. PubMed ID: 18095300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
    Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; Kiliç M
    Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative portal embolization in patients with hepatocellular carcinoma.
    Sugawara Y; Yamamoto J; Higashi H; Yamasaki S; Shimada K; Kosuge T; Takayama T; Makuuchi M
    World J Surg; 2002 Jan; 26(1):105-10. PubMed ID: 11898042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
    Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin.
    Shirabe K; Itoh S; Yoshizumi T; Soejima Y; Taketomi A; Aishima S; Maehara Y
    J Surg Oncol; 2007 Mar; 95(3):235-40. PubMed ID: 17323337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical indications for advanced hepatocellular carcinoma.
    Shimada M; Yamashita Y; Hamatsu T; Rikimaru T; Hasegawa H; Gion T; Shirabe K; Takenaka K; Sugimachi K
    Hepatogastroenterology; 2000; 47(34):1095-9. PubMed ID: 11020886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma].
    Park UJ; Kim YH; Kang KJ; Lim TJ
    Korean J Hepatol; 2008 Sep; 14(3):371-80. PubMed ID: 18815460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion: a single institution experience.
    Yoshidome H; Takeuchi D; Kimura F; Shimizu H; Ohtsuka M; Kato A; Furukawa K; Yoshitomi H; Miyazaki M
    J Am Coll Surg; 2011 May; 212(5):796-803. PubMed ID: 21530845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion.
    Aldrighetti L; Pulitanò C; Catena M; Arru M; Guzzetti E; Halliday J; Ferla G
    Ann Surg Oncol; 2009 May; 16(5):1254. PubMed ID: 19277788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.